Lin BioScience, Inc. (TPEX:6696)
Taiwan
· Delayed Price · Currency is TWD 119.00
+3.00 (2.59%)
Apr 24, 2025, 1:50 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 9.59 billion as of April 23, 2025. Its market cap has increased by 21.60% in one year.
Market Cap
9.59B
Enterprise Value
7.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
119.00
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 9.59B, an increase of 228.87%. That is a compound annual growth rate of 19.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 163.86B |
| Caliway Biopharmaceuticals | 93.22B |
| Bora Pharmaceuticals Co., LTD. | 67.36B |
| Lotus Pharmaceutical | 54.79B |
| Polaris Group | 30.00B |
| Oneness Biotech | 28.11B |
| Pegavision | 25.35B |
| Lumosa Therapeutics | 24.91B |